Login / Signup
Li Wang
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Pi K Akt
Signaling Pathway
Mouse Model
Top Venues
Oxidative medicine and cellular longevity
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Donglin Sun
,
Jing Guo
,
Weifei Liang
,
Yangxiao Chen
,
Xiangqiu Chen
,
Li Wang
Anlotinib Alleviates Renal Fibrosis via Inhibition of the ERK and AKT Signaling Pathways.
Oxidative medicine and cellular longevity
2023 (2023)
Donglin Sun
,
Jing Guo
,
Weifei Liang
,
Yangxiao Chen
,
Xiangqiu Chen
,
Li Wang
Anlotinib Alleviates Renal Fibrosis via Inhibition of the ERK and AKT Signaling Pathways.
Oxidative medicine and cellular longevity
2023 (2023)